ArticleDiagnostics (Basel, Switzerland)2021

Soluble High Mobility Group Box 1 (HMGB1) Is a Promising Biomarker for Prediction of Therapy Response and Prognosis in Advanced Lung Cancer Patients.

Nikolaus A Handke et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.